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Abstract  
Tropane alkaloids (TAs) are plant toxins that occur mainly in Datura, Atropa and 
Hyoscyamus sp, belonging to the Solanaceae family, besides a variety of other families 
such as Erythroxylaceae, Brassicaceae, Proteaceae, Euphorbiaceae, Rhizophoraceae, 
Convolvulaceae and Cruciferae. The TAs occur in all parts of the plants and botanical 
impurities have been found in a range of crops due to accidental contamination during 
harvesting. The intoxication via the food leads to anticholinergic effects (e.g. blurred 
vision, pupil dilation, dry mouth, vomiting, muscle spasms, tachycardia, etc.), 
culminating in severe intoxications and death. 
The EFSA CONTAM Panel established a group Acute Reference Dose (ARfD) of 0.016 
µg/kg body weight (b.w.) expressed as the sum of (-)-hyoscyamine and 
(-)-scopolamine, assuming equivalent potency. Infants and young children are the most 
exposed age classes as they consume a higher amount of cereal-based products per 
body weight. EFSA estimated that the dietary exposure of toddlers could be up to seven 
times the group ARfD. 
Recently, two European legislation acts were published in this field: Commission 
Recommendation (EU) 2015/976, recommending the monitoring of tropane alkaloids in 
certain food categories, and Commission Regulation (EU) 2016/239, enforcing maximum 
levels of tropane alkaloids in certain cereal-based foods for infants and young children. 
The EURL-Mycotoxins organised a proficiency test (PT) concerning the determination of 
atropine and scopolamine in cereal-based baby food, aiming to underpin and assess the 
measurement capability of Member States' (MS) laboratories. Particular focus was given 
to levels relevant for enforcement of legislation. Two samples were distributed to the 
participants: one sample labelled “C” – biscuits for infants containing approx. 1.2 µg/kg 
of atropine and 0.2 µg/kg of scopolamine, and one sample labelled “E” – cereals for 
porridge containing approx. 7.4 µg/kg of atropine and 1.0 µg/kg of scopolamine. 
Forty-eight datasets from 18 EU MS laboratories were received. Overall, 81 % of the z-
scores were in the range of -2 to 2 and 90 % were in the range of -3 to 3. For the lowest 
TA level (sample C) still 75 % of z-scores fell into an acceptable range (|z| ≤ 2), while 
the mass fraction of scopolamine was far below the target level of 1 µg/kg. In line with 
this observation, the vast majority of reported LOQs were below 1.0 µg/kg. The 
methodologies used by the participants can be clustered into three groups: the method 
supplied by the EURL; the RIKILT SOP A1070 and methods based on QuEChERS. The 
instrumental determination was by LC-MS/MS, with one exception (GC-MS). The 
recoveries reported by the participants were close to 95 %. No statistically significant 
dependence of the z-scores on the analytical methodology was observed. 
These results support the assumption that atropine and scopolamine can be reliably 
determined at the maximum levels proposed by the EU to ensure the protection of 
infants and young children's health using state-of-the-art analytical instrumentation. 
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1. Introduction  
 
Tropane alkaloids (TAs) are secondary metabolites naturally occurring in plants of 
several families including Brassicaceae, Solanaceae (e.g. mandrake, henbane, deadly 
nightshade, Jimson weed) and Erythroxylaceae, amongst others [1]. 
Datura stramonium, also known as Jimson weed or thorn apple, is widely distributed in 
temperate and tropical regions. Seeds of this plant have been found as impurities in 
important agricultural crops such as linseed, soybean, millet, sunflower and buckwheat 
and products thereof. Other well-known TA containing plants are the deadly nightshade 
(Atropa belladonna) and henbane (Hyoscyamus niger) as well as mandrake (Mandragora 
officinarum). The TA class contains over 200 compounds, but the most common ones are 
atropine and scopolamine. 
The consumption of small quantities of parts from these plants has caused severe 
intoxication, including deaths in young children [1]. As a result of the anticholinergic 
activity of the tropane alkaloids, the following symptoms may be observed: blurred 
vision, pupil dilation, dry mouth, vomiting, clouded consciousness, muscle spasms, low 
body temperature, hallucinations, tachycardia, and ultimately death. 
Tropane alkaloids occur in all parts of the plants and the content (up to 0.5 % in Datura 
spp and 1 % in Atropa spp) is such that a small portion (few mg of plant material per kg 
of goods) is enough to contaminate that product at a level of a few µg/kg. 
The most studied TAs, which are biologically active are (-)-hyoscyamine and 
(-)-scopolamine enantiomers. During sample preparation, (-)-hyoscyamine racemizes to 
(+)-hyoscyamine and the mixture is called atropine. Due to analytical constraints, it is 
not always possible to distinguish between the enantiomers of hyoscyamine; therefore, 
atropine (and scopolamine) are usually determined. Their structures can be found below. 
 
                                    
      Scopolamine      Atropine 
A survey conducted in The Netherlands in 2011, 2012 and 2014 investigating the 
presence of TAs in cereal-based food for infants and young children resulted in average 
TA levels of 4.6, 4.4 and 0.5 µg/kg, respectively, with maximum levels of 80.8, 57.6 and 
3.9 µg/kg. The ARfD established by EFSA (0.016 µg/kg body weight (b.w.)) would 
actually have been exceeded for 8 of the 93 products sampled in 2011 and 2012 [2]. 
Taking into consideration the available scientific evidence, the European Commission has 
published a recommendation to Member States (Commission Recommendation (EU) 
2015/976)  to monitor the presence of tropane alkaloids in food, in particular: cereals 
and cereal-derived products, gluten-free products, food supplements, teas and herbal 
infusions and, legume vegetables (without pods), pulses and oilseeds and derived 
products. The limit of quantification of the analytical method for determination of TAs in 
cereal-based foods for infants and young children should be preferably below 1 µg/kg 
[3]. 
A proficiency test (PT) was organised by the EURL-Mycotoxins to underpin and assess 
the measurement capacity of laboratories in the Member States (MS) concerning the 
Commission Regulation (EU) 2016/239, enforcing maximum levels of tropane alkaloids 
in certain cereal-based foods for infants and young children [4]. Laboratories that didn't 
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have a method already implemented for the determination of atropine and scopolamine 
in the relevant matrices were offered the possibility to request a suitable method 
description. The laboratories were required to analyse atropine and scopolamine in two 
cereal-derived products for infants and young children in the range of 0.2-7.4 µg/kg. 
 
2. Scope  
As stated in Article 32 of Regulation (EC) No 882/2004 [5], one of the core duties of the 
EURL is to organise proficiency tests for the benefit of the NRLs. In view of the recent 
and foreseen EU legislation on tropane alkaloids in food at the time of planning this 
study [3, 4], the EURL-Mycotoxins organised a proficiency test on the determination of 
tropane alkaloids (atropine and scopolamine) in cereals and cereal products (in the 
range of 0.2-7.4 µg/kg). The proficiency test was addressed to the EU Member States' 
competent laboratories (designated by the national competent authority) plus expert 
laboratories from industry and academia. Participation was free of charge. Fifty-two 
laboratories from 18 MS registered for the PT. 
 
The EURL-Mycotoxins performed the planning, execution and assessment of the 
measurement results on the basis of the requirements laid down in ISO/IEC 17043:2010 
[6]. Participant’s results were evaluated using the ProLab software package (Quodata, 
Dresden, DE). The team who organized this PT is an ISO/IEC 17043:2010 accredited PT 
provider [7]. 
 
3. Confidentiality  
Confidentiality of the identity of the participants and their results towards third parties is 
guaranteed.  
 
4. Time frame  
The PT was announced on the EURL-Mycotoxins webpage [7] on 29 September 2015 and 
through the EU CIRCABC database on 04 October 2015. Registration for this PT was 
initially open until 06 November 2015 and then extended until 06 January 2016 (Annex 
9.1). The participants were given six weeks after dispatch of the samples (18 and 19 
January 2016) for sending their results along with a questionnaire duly filled. The 
deadline for reporting the results was 02 March 2016. 
 
5. Materials  
5.1. Preparation  
Two different cereal-derived products were purchased in the local retail market: biscuits 
for infants (Sample C) and cereals for the preparation of porridge (Sample E). These 
materials were milled with a Retsch ZM 200 centrifugal mill (Retsch GmbH, Haan, 
Germany) to pass a 2 mm sieve. The materials were spiked with suitable amounts of a 
Datura stramonium (stems) extract in methanol to resemble, as much as possible, a 
natural contamination. Therefore, the proportion of atropine to scopolamine levels and 
co-extracted soluble constituents were kept as native as possible. The materials were 
spiked, then thoroughly homogenised in a tumbler mixer, bottled and stored in the 
freezer until dispatch. Batches of approximately 3 kg of both materials were prepared, 
and 15 g portions were packed in amber plastic bottles. 
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5.2. Homogeneity  
For testing the homogeneity of the PT materials, 10 units per material (Samples C and 
E) were selected randomly. Two independent determinations per bottle were performed 
using a liquid chromatography-isotope dilution tandem mass spectrometry detection 
(LC-ID-MS/MS) based method. The homogeneity was evaluated according to the ISO 
13528:2015 standard [8]. The materials proved to be adequately homogeneous (Annex 
9.2). 
 
5.3. Stability  
The stability study was conducted following an isochronous experimental design [9];-70 
°C was chosen as the reference temperature for sample storage. The periods of time 
considered for this study were: 14 days, 28 days and 48 days. The stability was 
evaluated according to the requirements of the ISO 13528:2015 [8]. A linear regression 
was drawn for each tested temperature over the duration of the assay and the 
significance of the slope departure from zero at 95 % confidence level was verified 
(Annex 9.3). The materials proved to be adequately stable at room temperature (≈20 
°C, 4 °C and -18 °C for the period between dispatch (t=0) and the deadline for 
submission of results (t=48 days). 
 
5.4. Distribution  
The test materials were dispatched on 18 and 19 January 2016 in polystyrene boxes, 
containing cooling packs. The samples were mostly received within 24 hours after 
dispatch. The materials were shipped such that +4 °C was not exceeded.  
 
Each participant received: 
a) two test materials for analysis, packed in amber plastic bottles 
- Sample C - biscuits for infants 
- Sample E - cereals for porridge 
b) two amber glass ampoules containing 
- Isotope labelled Internal Standard Solution (ISTD mix) 
- Tropane Alkaloids Standard solution (TA mix) 
c) accompanying letter with instructions on sample handling and reporting (Annex 9.4) 
d) sample receipt form (Annex 9.5) and 
e) laboratory specific reporting files with a lab code (by email). 
 
6. Instructions to participants  
The laboratories were required to report the mass fractions of atropine and scopolamine 
(in µg/kg to the nearest 0.01 µg/kg). Then, in the Questionnaire (Annex 9.6), 
participants were asked to mention whether the results were corrected for recoveries 
or not and to provide the recoveries figures (in %).  
The results were reported by the participants using RingDat software, which is part of 
the ProLab software. Laboratory specific files generated by the ProLab software were 
sent to each laboratory by email. A specific questionnaire was also included. The 
questionnaire was intended to provide further information on method-related and 
laboratory details to allow insights on possible individual and general effects observed for 
discussion at the next EURL/NRL workshop. Method-related details and performance 
parameters such as chromatographic conditions, MRM transitions, S/N ratio of peak 
signals (as peak-to-peak, instead of RMS) and LOQs were requested. 
Participants received information that the materials were shipped with cooling packs and 
that upon arrival, the materials needed to be stored at -18 °C until the analysis was 
performed. Participants were encouraged to perform the analysis as soon as possible. 
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7. Reference values  
The assigned values of the measurands in the test samples were established by Exact-
Matching Double Isotope Dilution Mass Spectrometry (EMD-IDMS) at JRC-Geel. This 
methodology provides the best possible accuracy [10].  
Table 2: Assigned values and their associated expanded uncertainties for both materials 
(samples C and E). 
  
Analyte/sample 
Assigned value 
µg/kg 
U (k=2) 
µg/kg 
Atropine/sample C 1.16 0.11 
Scopolamine/sample C 0.183 0.033 
Atropine/sample E 7.44 0.29 
Scopolamine/sample E 1.03 0.07 
 
U - expanded uncertainty of the assigned value 
 
8. Evaluation of the results  
8.1. General observations  
Out of the 52 laboratories that received the PT samples, 48 reported back their results. 
Four laboratories did not report due to technical problems. 
The laboratories were free to use their method of choice. An LC-MS/MS-based SOP for 
the determination of TAs in cereals was provided to those laboratories that did not have 
a method beforehand. This was the method developed, validated and used by the EURL 
Mycotoxins. This method consists of an extraction of the sample with a mixture of 
MeOH: H2O: formic acid (39:60:1) by shaking for 1 hour. The extract is analysed by LC-
MS/MS with a column containing a pentafluorophenyl stationary phase, and MilliQ water 
and acetonitrile (both containing 0.1 % formic acid) as mobile phases.  
Forty-seven laboratories used an LC-MS/MS technique for the determination of TAs in 
cereal while one laboratory used GC-MS. 
 
8.2. Scores and evaluation criteria  
The individual laboratory performance was assessed in terms of z-scores following the 
ISO 13528:2015 [8]. 
 
z=        Equation 1. 
where: 
xlab is the measurement result reported by the participant 
Xref is the reference value (assigned value) 
σp is the standard deviation for proficiency assessment (target standard deviation) 
 
σp was calculated using the Horwitz equation, modified by Thompson [11] for analyte 
concentrations < 120 µg/kg: 
 
- for analyte concentration < 120 µg/kg 
        Equation 2. 
 
pσ
reflab Xx −
cp ⋅= 22.0σ
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where: 
c = concentration of the measurand (assigned value, Xref) expressed as a dimensionless 
mass ratio, e.g. 1 µg/kg = 10-9, 1 mg/kg = 10-6 
 
The z-score compares the participant's deviation from the reference value with the 
target standard deviation accepted for the proficiency test, σp. The z-score is interpreted 
as follows: 
|z| ≤ 2  acceptable result 
2 < |z| < 3  questionable result 
|z| ≥ 3   unacceptable result 
 
8.3. Laboratory results and scoring  
The statistical evaluation of the results was performed using the ProLab software [12]. 
The robust mean and reproducibility standard deviation were computed according to 
Algorithm A of ISO 13528:2015, and are given just for information purposes [8]. Z-
scores were calculated for scopolamine and atropine considering as target concentrations 
the values assigned by EMD-IDMS. The target values were in good agreement with the 
consensus values (robust mean). 
81.2 % of the results reported by the participants obtained acceptable z-scores, |z| ≤ 2. 
10.3 % of the results (16 results) fell into the unacceptable performance range, |z| ≥ 3 
(Figure 1). 
 
Figure 1 - Distribution of all z-scores across measurands/samples/laboratories. 
 
Figure 2 provides an overview of the individual z-scores assigned to the results 
submitted by the laboratories for atropine and scopolamine in the two cereal test 
materials. The longer the triangles, the larger were the differences to the assigned 
values. Yellow triangles represent z-scores in the questionable range and red triangles in 
the unacceptable performance range. The corresponding scores are shown next to the 
triangles. 
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Figure 2 - Distribution of z-scores based on the assigned values for each combination of 
sample (C and E) and measurand (atropine-ATROP and scopolamine-SCOP). 
 
The numerical values of the calculated z-scores are compiled in Table 3. All z-scores in 
the questionable performance range are shown with a yellow background, while z-scores 
indicating unacceptable performance are presented with a light-red background. This 
mode of presentation allows for easy distinction between the two performance ranges, 
even on black-and-white prints. 
 
Table 3: Analytical results and respective z-scores for TAs in samples C and E.  
 (Colour code: yellow – questionable, red – unacceptable) 
 
 Sample C Sample E 
Lab. ATROP 
µg/kg 
Z score 
  
SCOP 
µg/kg 
Z score 
  
ATROP 
µg/kg 
Z score 
  
SCOP 
µg/kg 
Z score 
  
2 1 -0.6 < 0.30   7.12 -0.2 1.04 0.1 
4 1.18 0.1 0.25 1.7 9.46 1.2 1 -0.1 
5 1.24 0.3 0.31 3.2 8.77 0.8 1.11 0.4 
6 1.22 0.2 0.35 >4 7.23 -0.1 1.32 1.3 
7 2.71 >4 0.22 0.9 11.88 2.7 0.98 -0.2 
8 1.46 1.2 < 0.50   8.35 0.6 1.15 0.5 
9 2.43 >4 < 1.00   8.65 0.7 1.66 2.8 
10 1.23 0.3 0.15 -0.8 9.82 1.5 1.07 0.2 
Z-Score
-3 0 3 -3 0 3 -3 0 3 -3 0 3
Sample/Measurand
C/ATROP C/SCOP E/ATROP E/SCOP
La
bo
ra
to
ry
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
44
45
46
47
49
50
51
52
6.1
5.0
4.5
4051.1
3.7
3.2
4.1
1225.0
194.2
6.4
12.8
14.3
3751.8
76.8
3333.8
-3.2
-3.6
  
13
11 1.5 1.3 49.5 >4 7.5 0.04 18.4 >4 
12 < 5.00   < 5.00   9.8 1.4 < 5.00   
13 1.19 0.1 0.28 2.4 7.6 0.1 0.96 -0.3 
14 1.01 -0.6 0.28 2.4 5.93 -0.9 1.09 0.3 
15 1.07 -0.4 0.12 -1.6 7.28 -0.1 0.63 -1.8 
16 0.99 -0.7 < 0.60   7.94 0.3 1.32 1.3 
17 1.4 0.9 < 1.00   7.49 0.03 1 -0.1 
18 1.34 0.7 < 0.30   10.04 1.6 1.03 0 
19 1.32 0.6 0.16 -0.6 8.49 0.6 0.88 -0.7 
20 < 2.00   8 >4 5.8 -1 < 2.00   
21 2.32 >4 0.44 >4 4.67 -1.7 1.54 2.3 
22 1.46 1.2 < 1.00   9.39 1.2 1.26 1 
23 1.8 2.5 0.7 >4 9 1 1.6 2.5 
24 not tested   not tested   6 -0.9 1.12 0.4 
25 1.53 1.4 0.25 1.7 11.25 2.3 1.04 0.1 
26 1.69 2.1 < 0.20   9.32 1.1 1.36 1.5 
27 1.37 0.8 0.26 1.9 8.58 0.7 1.09 0.3 
28 1 -0.6 0.2 0.4 5.1 -1.4 0.5 -2.3 
29 0.85 -1.2 < 0.20   6.03 -0.9 0.78 -1.1 
30 1.48 1.3 not tested   7.55 0.1 0.69 -1.5 
31 1035 >4 < 100.00   6150 >4 755 >4 
32 1.4 0.9 not tested   8.17 0.4 1 -0.1 
33 1.29 0.5 < 0.50   7.86 0.3 1.12 0.4 
34 1.18 0.1 0.04 -3.6 11.9 2.7 1.43 1.8 
35 0.35 -3.2 < 0.14   3.72 -2.3 0.53 -2.2 
36 1.24 0.3 0.17 -0.3 8.11 0.4 1.17 0.6 
37 1.11 -0.2 0.13 -1.3 6.68 -0.5 0.8 -1 
38 1.08 -0.3 0.16 -0.7 7.54 0.1 1.04 0 
39 1 -0.6 0.2 0.4 7.22 -0.1 1.15 0.5 
40 1.01 -0.6 < 0.41   6.5 -0.6 0.83 -0.9 
41 1.07 -0.4 0.18 -0.1 7.33 -0.1 0.84 -0.8 
42 2.1 3.7 not tested   8.9 0.9 1.5 2.1 
44 < 1.00   < 1.00   5.9 -0.9 < 1.00   
45 1.26 0.4 0.17 -0.3 8.84 0.9 1.19 0.7 
46 1.23 0.3 0.17 -0.3 8.02 0.4 1 -0.1 
47 1.16 0 0.16 -0.6 10.42 1.8 1.22 0.8 
49 1.01 -0.6 0.17 -0.3 7.57 0.1 0.96 -0.3 
50 1 -0.6 not tested   7.5 0.04 1 -0.1 
51 1.11 -0.2 0.11 -1.8 7.9 0.3 0.84 -0.8 
52 1.3 0.5 0.76 >4 6.61 -0.5 1.26 1 
 
The results are written as reported by the laboratories. 
 
The graphical representations of the distribution of the results (µg/kg) for each 
combination of measurand/sample are given in Figure 3. Reported results are shown as 
bars. The green line corresponds to Xref; the green shadow covers the boundary of the 
reference interval (Xref ± uref), and the red lines mark the boundary of the target 
interval (Xref ± 2σ). Yellow bars represent results with |z-score| <3 while red bars 
represent unacceptable results. 
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Figure 3 - sigmoidal distribution of the individual laboratory values as reported for 
atropine and scopolamine in samples C and E. 
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Figure 4 - Kernel density plots of the reported values for atropine (ATROP) and 
scopolamine (SCOP) in samples C and E. 
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It should be noted that the confidence intervals of the assigned values always overlap 
with the confidence intervals of the robust means calculated from the participants' 
results (Kernel density plot). In particular, a very good match is observed between the 
target values assigned by IDMS and the main mode of the kernel distribution. This is due 
to the fact that the robust mean is still influenced by extreme values outside the z-score 
limit on the higher end; see red flagged bars in Figure 3. 
The robust standard deviations of the reported results for both TAs in the cereal test 
materials are also in good agreement with the target standard deviations, except for the 
low level of scopolamine in sample C, close to the LOQ (see Table 4). 
As it could be seen from the Kernel density plots, the dispersion of the results 
approximate a Gaussian distribution. The major mode is close to the assigned 
(reference) value and the robust mean calculated from the results of the participants. 
This supports the conclusion that the measurement of atropine and scopolamine in 
cereal samples follows a normal distribution. 
 
Table 4: Summary of the statistical evaluation of the results for scopolamine and 
atropine in the test samples. 
 
 Units Scopolamine/ 
sample C 
Scopolamine/ 
sample E 
Atropine/ 
sample C 
Atropine/ 
sample E 
No. of laboratories that 
submitted results 
 43 48 47 48 
No. of participants 
(according to design) 
 48 48 48 48 
Assigned (Reference) 
value 
µg/kg 0.183 1.03 1.16 7.44 
Uncertainty of the 
assigned value (k=2) 
µg/kg 0.033 0.07 0.11 0.29 
Mean (robust) µg/kg 0.24 1.09 1.27 7.97 
Target s.d. µg/kg 0.04 0.23 0.26 1.64 
Reproducibility s.d. µg/kg 0.12 0.28 0.29 1.67 
Rel. SDPA % 22.0 22.0 22.0 22.0 
Rel. reproducibility s.d. 
(robust) % 66.7 26.9 24.6 22.5 
 
 
9. Evaluation of the questionnaire  
The questionnaire distributed to the participants has provided very useful information 
concerning the approaches and capabilities of the participating laboratories on the 
determination of tropane alkaloids in food products. 
The questionnaire will be discussed in 3 sections: 
1) the first section will present the outcome of the Yes/No answers regarding the 
previous experience of the participants and general organisational matters: questions 1-
4, 31-35 and question 30 of Annex 9.6.  
2) the second section will deal with the outcome of the Yes/No answers concerning 
analytical aspects: questions 13-14, 20-21, 24-25, 27-29 and 36 of Annex 9.6. 
3) the third section will give a more extensive overview of the analytical conditions used 
by the participants for the determination of tropane alkaloids in cereal products: 
questions 5-12, 15-19, 22-23, 26 and 37 of Annex 9.6. 
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9.1. Experience and organisational aspects  
In Table 5, the number of responses received and the percentage of Yes/No answers 
regarding the experience of the participants and general organisational matters are 
compiled. Around 60 % of the participants declared to have prior experience in the 
analysis of TAs (Q.1). A large majority of these were just capable of determining 
atropine and scopolamine and the most common matrices were cereals and baby food 
products. The majority of laboratories had less than two years' experience in this field, 
except 2 cases (>5 or 10 years). Two laboratories are capable of analysing a range of 
TAs, up to 20, which may include: acetylscopolamine, anisodamine, anisodine, 
apoatropine, aposcopolamine, atropine, convolamine, convolidine, convolvine, fillalbin, 
homatropine, hydroxymethylatropine, littorine, noratropine, norscopolamine, 
phenylacetoxytropane and scopolamine. There were also five laboratories that analyse 
atropine and scopolamine in tea and herbs. 
 
Table 5: Response to the questions related to the experience of the participants on the 
determination of tropane alkaloids in cereals and organisational aspects of the PT 
 
 Q.1 Q.3 Q.13 Q.20 Q.24 Q.25 Q.28 Q.31 Q.32 Q.34 Q.35 
Response - NO 
Nr. 19 17 23 17 0 2 39 2 8 25 3 
% 40 36 49 36 0 4 83 4 17 63 7 
Response - YES 
Nr. 28 30 24 30 47 43 8 45 39 15 41 
% 60 64 51 64 100 96 17 96 83 38 93 
 
When inquired whether they were capable of analysing other plant toxins (Q.3), 64 % 
answered positively; however 8 laboratories answered wrongly indicating mycotoxins. 
The plant toxins of major concern, in addition to the tropane alkaloids, were: 
pyrrolizidine, opium and quinolizidine alkaloids, following this ranking. Overall, 16 
laboratories declared to be able to analyse pyrrolizidine alkaloids, while 7 can do ergot 
alkaloids analysis. This demonstrates that a wide range of these toxins can already be 
determined in food products, mainly through multi-toxin LC-MS/MS methods. 
Regarding the satisfaction with the organisational aspects of the PT, the participants 
were asked to express their opinion on whether the time for reporting the results was 
adequate (Q.31), the length of time they spent for issuing the results (Q.33) and 
whether the sample amount was sufficient for their needs (Q.32). Ninety-six percent of 
the participants did not find any limitation in the allocated time for reporting back the 
results (6 weeks). In fact, about 38 % of the participants could perform the analysis of 
the samples, treat the data and issue the results in 2 days while 12 % did it in just 1 
day. Forty-eight percent of the participants indicated that they needed more than 2 
days. The major limitation may have been related to technical problems with the 
instruments, as LC-MS/MS equipments require frequent maintenance and/or repair. 
Eighty-three percent of the participants found the amount of sample dispatched (15 g) 
enough for performing the analysis (Q.32). 
The major complaints were related to the process of results reporting, more precisely, 
the questionnaire filling, using the RingDat software (Q.34). Thirty-eight per cent of the 
participants experienced problems, which were timely communicated to us, and 
deserved our highest priority. As it is a relatively new software solution, the participants 
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were informed to acquaint themselves with it in advance. Below is a list of the remarks 
received: 
 
- It was not possible to save all the data filled in the fields to answer the questions. Esp. Q 10, 11 
and 12. 
- It crashed once, something on the system resources in German was reported 
- Difficulties to download ringdat, breakdown 
- While saving data for the first time, a number of messages in German appeared. Even Task 
Manager was not able to stop application (another series of messages). But after restarting the 
computer everything was fine, and all data were saved. 
- It kept crashing / locking me out and I lost entries several times so had to repeat the reporting 
process! 
- The .LA2 file was impossible to open. 
- Could not open file: 32.LA2, filling in result form is much easier, as multiple people can log on, 
Download for result submission is often complicated, as administration rights for computer usually 
belong to IT department 
- Some data would not save (ion details + CID etc) 
- At first input of results, the program resources were overloaded and the program crashed. The 
already inputted data was lost 
- System was shut down during data entry 
- Software very instable; during the input repeated crashs 
- Sometimes no free text available (e.g. 24, 27). Once a choice has been made it can't be deleted.  
- The software often crashes immediately. 
- System is very unstable; it crashed several times during use 
- Too long the overall procedure for reporting back the results. The error messages are not in 
english 
 
Overall, 93 % of the participants found the instructions (Annex 9.4) appropriate and 
sufficiently explanatory (Q.35).  
The participants were informed about this PT through different routes, sometimes 
cumulatively (Q.30). According to the table below, most participants knew about the PT 
by direct invitation through mailings from the European Commission CIRCABC database 
or by the NRLs contact. 
 
Information source about the PT TAs in cereal products % 
Through the EURL Mycotoxins website 16 
During the EURL workshop for the NRLs on mycotoxins 11 
By invitation from the European Commission communication office 30 
By the NRL in your country 20 
By professional associates in your sector 13 
Other 11 
 
9.2. Analytical aspects  
When asked whether the analytical method used for analysing TAs in the PT samples 
was validated (Q.13, Table 4), about 50 % of the participants replied that they have not 
collected validation data. This finding might be explained by the fact that many 
laboratories have implemented the method just before the proficiency test, and 
therefore didn't have enough time to validate the method properly. 
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Of those who validated the method, the recoveries and the LOQs were estimated by 
78 % of the laboratories while the precision, linearity and LOD were estimated by just 
65 % of the laboratories. Only one laboratory stated to have estimated the 
measurement uncertainties. This figure of merit was not asked for this PT. 
As isotope-labelled internal standards for atropine and scopolamine are commercially 
available, the participants were asked whether they used this strategy (isotope dilution 
MS) for quantification (Q.20). Sixty-four percent of the participants answered positively. 
The majority of them (91 %) added the internal standards before the extraction while 
9 % added the internal standards after the extraction (Q.21). The first approach 
provides more benefits as the internal standards can correct the results simultaneously 
for the losses during the extraction step and also compensate the matrix effects during 
MS analysis. 
All the participants have checked the integration of the chromatographic peaks (Q.24) 
while 96 % also checked the goodness of fit of the calibration curve in the region where 
the signal of the samples is interpolated (Q.25). 
Additionally, the participants were asked to indicate whether the results reported were 
corrected for recoveries or not corrected for recoveries, following their normal 
routine procedures (Q.26). Forty-three per cent answered that they had corrected the 
results for recoveries while 55 % declared that they didn’t. Nevertheless, the answer to 
this question has to be analysed in relation with Q.21. Whenever the participants stated 
that the internal standards were added to the sample before the extraction and given 
that an internal calibration was used, the obtained results were automatically corrected 
for the recoveries without any further calculation. In light of this, the results that have 
been reported without correction for recoveries might be just 21 %. 
Regarding the satisfaction of the participants with the structure of the PT, 83 % declared 
that they didn't experience any major difficulties analysing the distributed samples 
(Q.28). Those who experienced problems reported issues related to the matters 
mentioned in the table below (copied from the questionnaire). On average, the analyst 
responsible for conducting the PT had >7 years of experience. 
 
- Low levels of atropin and scopolamin in the samples (<0.1µg/kg) 
- The samples lumped during the first extraction step 
- Sensitivity of the instrument 
- Purchase of standards but the main difficulty was the extraction of samples. It seems that the 
used one is not appropriate enough 
- Very limited amount of sample (not enough to perform e.g. a final standard addition approach)/ 
without further clean-up LOQ of 1 µg/kg is difficult to reach  / Around 15g of sample is not 
enough to get good and correct results. It should be at least 200g or even more 
- Sensitivity of the instrument 
- Not stable sensitivity of the instrument 
- Too close to LOD/LOQ 
The mentioned remarks related to the low levels of TAs in the samples vs. insufficient 
sensitivity of the instruments affected just a limited number of participants. Eight 
participants would have preferred to receive a higher amount of sample. 
Below is a compilation of the general comments (Q.36), received from the participants 
including both analytical information and reporting improvement opportunities. 
- See email text because here it is not possible to submit all the data, because we were not able 
to save it. After saving it was deleted automatically by the ringdat software. 
- As our RR% were calculated in raw buckwheat by spiking, we didn't apply any recovery 
correction to the dispatched samples. We did not use isotopic std, since the solutions were slightly 
opaque after preparation (possible interferences?). 
- We used standard addition for quantification purposes. Our own atropin and scopolamin 
standard solution have much lower response values for the same concentrations (we prepared the 
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solutions freshly) 
- Results reported are inherently corrected for the isotopically labelled internal standard used 
during the analysis. Recovery values reported are for information only, and were from samples 
spiked at 10ug/kg analysed at the same time to provide additional information on method 
performance. 
- A blank  from the same matrix would have been useful 
- Question No 24: Approach for calibration: We use the procedural standard calibration which 
automatically corrects for recovery losses as well as matrix effects 
- A blank for the matrix-matched calibration and recovery experiments would have been really 
helpful 
- We did the matrix calibration with an uncontaminated rye flour, because we did not know which 
matrix exactly you sent to us. We didn´t want to use the contaminated material for spiking. Our 
reported results were the mean value of four. 
- For the small amounts of sample C we did a standard addition to calculate contents 
- Please make the form printable! 
- In our method matrix matched calibration is only used to check the linearity and sensitivity of 
the system. Actual quantitation is performed by standard addition to the sample (in this case 25 
ug/kg) 
- Sample E064 seems to contain a small amount of anisodamine, aprox. 0.74 µg/kg; Recovery in 
this PT was calculated by means of the internal standard. 
 
9.3. Methods' overview 
Along with the analytical results, the participants in this PT also submitted a compilation 
of some figures of merit and a description of core methodological features. In Annex 
9.7.1, the reported limits of quantification (LOQs), recoveries (%), matrix suppression 
(MatrixSup, %) and retention times (RT, min) for both atropine and scopolamine are 
shown. As it can be seen in the histograms below (Figure 5), a vast majority of the 
reported LOQs fall below 1 µg/kg, therefore, the state-of-the-art instrumentation used 
provided sufficient sensitivity to yield signals for quantification. The majority of the 
applied methods resort to a simple "dilute and shoot" approach (Annex 9.7.2, Question 
7). 
On average, the participants reported recoveries close to 95 % for both atropine and 
scopolamine, though with a bigger dispersion in the latter case (Figure 6). Given the 
diversity of extraction methods applied (Question 6: shaking, QuEChERS, different 
solvent compositions), these figures fall within an acceptable range. However, it is 
unknown whether they are relative recoveries, absolute recoveries or a combination of 
both. 
As far as the matrix effects (matrix suppression) are concerned, they span a wide range. 
However, no objective interpretation can be made as, apparently, the participants 
reported their values in different units. 
An overall evaluation of the analytical methodologies employed (Annex 9.7.2) indicated 
that 10 laboratories applied the EURL-developed method, as they did not have any 
previous method implemented. Five laboratories applied the RIKILT SOP A1070 while an 
additional three laboratories applied the method described in Adamse, P; van Egmond 
H.P. (2010): Report 2010.011, which follows a similar principle. Four laboratories 
declared that they used a QuEChERS clean-up while five others followed the reference: 
Jandric et al., Food Additives and Contaminants 28 (9) (2011) 1205-1219, which 
describes also a QuEChERS-related clean-up. Eighteen laboratories stated that they used 
either an in-house developed method or the reference did not allow grouping them in 
any of the previous categories. All the laboratories resorted to LC-MS/MS for separation 
and detection, except one laboratory that used GC-MS after derivatisation of the 
analytes with BSTFA/TMCS. An evaluation of the performance of the laboratories did not 
reveal any dependence on the methodology used, with statistical significance. 
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Figure 5 – Histograms of the methods' LOQs for atropine and scopolamine in cereal 
samples  
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Figure 6 – Histograms of methods' recoveries (%) for atropine and scopolamine in 
cereal samples.   
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Histogram of Scopolamine
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10. Conclusions 
The EURL-Mycotoxins organised a proficiency test on the determination of tropane 
alkaloids (atropine and scopolamine) in cereal-based baby food upon the DG SANTE 
request. Both the sample matrices and measurand levels were targeted to provide 
insight on the measurement capabilities of EU Member States' laboratories concerning 
the implementation of recently published legislation in this field (maximum limits of 
atropine and scopolamine of 1.0 µg/kg, Commission Regulation (EU) 2016/239). 
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Fifty-two laboratories registered for this PT, of which 48 participants from 18 EU Member 
States submitted their results. Twenty-one participants were from Germany, four from 
Italy and three from Spain, with the remaining countries having one or two 
representatives. 
Overall, 81 % of the z-scores were in the range of [-2 to 2] and 90 % were in the range 
of [-3 to 3]. At the lowest TA level (sample C), 75 % of z-scores fell within an acceptable 
range (|z| ≤ 2), while this figure improved to 86 % at the highest level (sample E). For 
atropine, 86 % of the results were in the acceptable range (|z| ≤ 2) while for 
scopolamine 75 % were in the same range in the two cereal samples. This does not 
necessarily mean that scopolamine entails a more difficult analysis as the concentration 
levels were constantly lower than atropine.  
The majority of reported LOQs fell below 1 µg/kg. The extraction conditions used by the 
participants can be clustered in 3 groups: method supplied by the EURL; RIKILT SOP 
A1070 and QuEChERS with final determination of the analytes by LC-MS/MS, with one 
single exception (GC-MS). The recoveries reported by the participants were close to 95 
%. No statistically significant dependence of the z-scores on the analytical methodology 
applied neither on the source of the standards was observed. 
These results support the assumption that atropine and scopolamine can be reliably 
determined at the levels regulated by the Commission Regulation (EU) 2016/239, using 
the state-of-the-art analytical instrumentation. A good overall performance in the PT was 
observed although some laboratories have just implemented the method prior to the PT. 
The outcome of this PT should help the laboratories to consolidate and improve their 
analytical competence where needed.  
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List of abbreviations and definitions  
ACN  Acetonitrile 
EURL  European Union Reference Laboratory 
GC-MS  Gas chromatography-mass spectrometry 
HPLC  High-performance liquid chromatography 
EMD-IDMS Exact matching double isotope dilution mass spectrometry 
ISO  International Organization for Standardization 
JRC  Joint Research Centre 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LOD  Limit of Detection 
LOQ  Limit of Quantification 
NRL  National Reference Laboratory 
OCL  Official Control Laboratory 
PT  Proficiency Test 
SOP  Standard operating procedure 
SDPA  Standard deviation for proficiency assessment 
s.d.  Standard deviation 
TA  Tropane alkaloids 
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9. Annexes 
9.1. Opening of registration 
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9.2. Homogeneity test 
 
Homogeneity according to ISO 
13528:2015 [8] 
Sample C Sample E 
Atropine Scopolamine 
Mean 1.003 1.076 
σˆ  0.221 (22 %) 0.237 (22 %) 
0.3 σˆ (critical value) 0.066 0.071 
SX (standard deviation of sample averages) 0.063 0.115 
SW (within-sample standard deviation) 0.157 0.159 
SS (between-sample standard deviation) 0.000 0.025 
SS < 0.3 σˆ  Passed Passed 
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9.3. Stability study 
 
Stability study – Sample C 
 
 
Atropine Scopolamine 
T (ºC) Slope Lower 
95 % * 
Upper 
95 % * 
Null 
slope 
Slope Lower 
95 % 
Upper 
95 % 
Null 
slope 
-18 0.00037 -0.00171 0.00245 YES 0.00011 -0.00068 0.00089 YES 
4 0.00073 -0.00172 0.00319 YES -0.00016 -0.00088 0.00055 YES 
20 0.00124 -0.00238 0.00486 YES 0.00004 -0.00083 0.00092 YES 
 
* Upper and lower intervals of the regression slope at 95 % confidence level. 
 
 
Stability study – Sample E 
 
 Atropine Scopolamine 
T (ºC) Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
Slope 
Lower 
95 % 
Upper 
95 % 
Null 
slope 
-18 -0.00117 -0.01928 0.01693 YES 
-
0.00014 -0.00338 0.00310 YES 
4 -0.00794 -0.02685 0.01098 YES 0.00013 -0.00232 0.00259 YES 
20 0.00850 -0.00231 0.01932 YES 0.00027 -0.00079 0.00133 YES 
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9.4. Accompanying letter 
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9.5. Acknowledgement of receipt form 
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9.6. Questionnaire 
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9.7. Experimental details 
9.7.1. Method performance characteristics 
 
Lab Sample LOQ 
(µg/kg) 
Atrop 
LOQ 
(µg/kg) 
Scop 
Rec (%) 
Atrop 
Rec (%) 
Scop 
MatrixSup 
(%) Atrop 
MatrixSup 
(%) Scop 
RT (min) 
Atrop 
RT (min) 
Scop 
2 
 
Sample C 0.3 0.9 100 100 100  5.78 4.78 
Sample E 0.3 0.9 100 100 100  5.78 4.77 
4 Sample C 0.2 0.2   60.8 54.8 6.78 6.42 
Sample E 0.2 0.2   48.6 42.9 6.78 6.42 
5 Sample C 0.25 0.25 101 100 1.04 1.01 10.4 7.4 
Sample E 0.25 0.25 101 100 1.36 1.25 10.4 7.4 
6 Sample C 0.5 0.5 91 66 96 85 2.95 2.48 
Sample E 0.5 0.5 93 69 97 87 2.95 2.48 
7 Sample C 2.5 2.5 110 93   2.4 2.2 
Sample E 2.5 2.5 110 93   2.4 2.2 
8 Sample C 0.5 0.5 95 115 45  6.4  
Sample E 0.5 0.5 95 115 35 35 6.4 5.3 
9 Sample C 1 0.3 104 98   7.95 5.25 
Sample E 1 0.3 104 98   7.95 5.26 
10 Sample C 108 94     
Sample E 108 94     
11 Sample C 1.5 0.5 98 103   15.25 15.95 
Sample E 1.5 0.5 92 94   15.25 15.95 
12 Sample C 5 5 100 100   2.91 2.97 
Sample E 5 5 100 100   2.91 2.97 
13 Sample C 0.5 0.5 91.2 86.6 95 65 6.7 5.6 
Sample E 0.5 0.5 91.2 86.6 95 65 6.7 5.6 
14 Sample C 0.2 0.3 80 85 59 68 6.81 2.69 
Sample E 0.2 0.3 80 85 45 79 6.82 2.69 
15 Sample C 0.1 0.1 95.2 75.3     
Sample E 0.1 0.1 95.7 67.3     
16 Sample C 0.6 0.6 113 121 72 65 5.72 4.68 
Sample E 0.6 0.6 117 131 54 43 5.67 4.63 
17 Sample C 1 1 106 94   1.22 1.09 
Sample E 1 1 100 99   1.22 1.09 
18 Sample C 0.3 0.3 94 82 81.2 77.9 8 6.85 
Sample E 0.3 0.3 78.5 95.5 71.8 59 7.93 6.8 
19 Sample C 0.2 0.2 90 90 145 121 8.9 6.8 
Sample E 0.02 0.2 90 90 145 121 8.9 6.8 
20 Sample C 5 5 79 98 35 12 0.98 0.79 
Sample E 5 5 78.9 98 35 12 0.98 0.79 
21 Sample C 0.31 0.44       
Sample E 0.31 0.44       
22 Sample C 1 1 82 82   1.57 1.33 
Sample E 1 1 82 82   1.57 1.33 
23 Sample C 0.5 0.5 84 63 102 120 2.95 2.76 
Sample E 0.5 0.5 79 75 109 104 2.95 2.76 
24 Sample C 0.28 1.62 108 210     
Sample E 0.17 0.86 88 165   9.57 8.51 
25 Sample C 0.17 0.33 62 89 96 52 6.4 5.3 
Sample E 0.17 0.33 36 106 69 35 6.3 5.2 
26 Sample C 0.3 0.2 85 85   5.44 4.68 
Sample E 0.2 0.2 85 85   5.43 4.68 
27 Sample C 0.5 0.5 86.6 96.5   4.03 4.04 
Sample E 0.5 0.5 83.5 94.8   4.19 4.2 
28 Sample C 0.3 0.3 100 100 1 0.6 9.3 7.9 
Sample E 0.3 0.3 100 100 0.6 0.4 9.3 7.9 
29 Sample C 0.7 0.7 80 86   5.1 4.7 
Sample E 0.7 0.7 80 86   5.1 4.7 
30 Sample C 1 0.5 100 100   3.56  
  
32
Sample E 1 0.5 100 100   3.58 2.92 
31 Sample C 100 200 113.8 121.3 123 107 4.4 2.6 
Sample E 100 200 113.8 121.3 137 127 4.4 2.6 
32 Sample C 1 1 72 58   3.83 3.73 
Sample E 1 1 72 58   3.83 3.72 
33 Sample C 1 1 105 97 110 102 4.82 2.49 
Sample E 1 1 105 97 111 102 4.82 2.49 
34 Sample C 2 2 113 110   2.71 1.94 
Sample E 2 2 104 106   2.71 1.94 
35 Sample C 0.25 0.25   - - 7.05 3.69 
Sample E 0.25 0.25   - - 7.06 3.71 
36 Sample C 0.3 0.3 100 100 11.86 8.34 4.31 3.46 
Sample E 0.3 0.3 100 100 12.41 8.3 4.28 3.42 
37 Sample C 0.1 0.1 100 100   7.02 4.68 
Sample E 0.1 0.1 100 100   7.02 4.68 
38 Sample C 1 2.5 94.18 97.88 93.1 47.8 3.17 1.64 
Sample E 1 2.5 94.18 97.88 93.1 47.8 3.16 1.63 
39 Sample C 0.2 0.3 97 99 84 84 6.12 4.84 
Sample E 0.2 0.3 97 98 75 65 6.14 4.87 
40 Sample C 0.12 0.41 104    7 6.36 
Sample E 0.12 0.41 114.3 96   7 6.36 
41 Sample C 0.2 0.2 109 101 47 55 2.37 2.01 
Sample E 0.2 0.2 107 89 66 69 2.35 2.01 
42 Sample C 5 5 99 97 0 0 6.43 5.68 
Sample E 5 5 99 97 0 0 6.43 5.68 
44 Sample C 1 1       
Sample E 1 1       
45 Sample C 0.3 0.3     10.2 8.7 
Sample E 0.3 0.3     10.2 8.7 
46 Sample C 0.5 0.25 85.1 87.5   7.99 7.25 
Sample E 0.5 0.25 91.9 90.4   7.99 7.25 
47 Sample C 0.1 0.1   27.7 31 6.48 5.39 
Sample E 0.1 0.1   77.64 76.95 6.48 5.39 
49 Sample C 0.26 0.27 88.5 98.3 59 86 3.65 2.84 
Sample E 0.26 0.27 88.5 98.3 45 60 3.65 2.84 
50 Sample C 1 1 91 88 91 88 4.1 3.6 
Sample E 1 1 91 88 91 88 4.1 3.6 
51 Sample C 0.5 0.5 83 89 207 63 5.9 4.76 
Sample E 0.5 0.5 98 74 165 81 6.13 4.92 
52 Sample C 0.5 0.5 83 89   5.9 4.76 
Sample E 0.5 0.5 98 74   6.13 4.92 
 
Atrop – atropine; Scop - scopolamine 
 
 
9.7.2. Analytical conditions 
 
Lab Q.5 
Reference of the SOP used 
Q.6 
Extraction details 
Q.7 
Concentration
/clean-up 
Q.8 
Solvent to 
sample ratio 
Q.9 
Mass fraction 
injected 
2 Jakabová et al. Journal of 
Chromatography A, 1232 (2012) 
295– 301 
1 min. vortex, 20 min 
sonication in: 300 mL MeOH 
+ 200 mL H2O + 0.5 mL 
FormAc 
Filtration; 
Dilute and 
Shoot 
1 g in 20 mL 0.0001 
4 Sample preparation procedure for 
the analysis of tropane alkaloides 
in food and feed by LC-MS/MS 
(RIKILT SOP A 1070) 
extraction time: 30 min / 0,4 
% formic acid in methanol / 
water (69:40) 
2 ml of the 
supernatant  
centrifuged 
with ultrafilter 
tubes (40kDa) 
2 g sample 
extracted with 
20 ml sol. 0.4 
% formic acid in 
MeOH/water  
60:40 (v/v) 
10 µl filtrate 
injected for LC-
MS/MS analysis 
5 Adamse, P.; Egmond, H.P. van; 
Noordam, M.Y.; Mulder, P.P.J.; 
Nijs, M. de, Quality Assurance 
and Safety of Crops & Foods 6 
(1) (2014) 15 - 24 
stir 45 min, pH9, Ammonium 
carbonate /Acetonitrile 16/ 
84 
Bondesil PSA 
40 µm 
5 g to 25 ml 
extraction 
solvent  
5g / 25ml / 1ml 
evaporate to 
dryness / 
reconstitute in 
5ml/ inject 10µl 
  
33
6 QuEChERS 5 min, blending with 
Geno/Grinder. Water (0.5 % 
acetic acid) and acetonitrile.  
QuEChERS EMR S/S=4. 2.5 g 
sample 
extracted with 
10 mL solvent. 
2 µL injected for 
LC-MS analysis. 
meq =0.0005 
7 Detection of ergot and tropane 
alkaloids by LC-MS/MS 
modified quechers / 4 g of 
sample / 30 mL ACN/H2O + 
2.1 mmol/L ammonium 
carbonate (84/16, v/v) / 45 
min rotate overhead / Add 
salts MgSO4 (4g) /NaCl (1g) 
/ Centrifuge at 10,000 rpm 5 
min / 2 mL of supernatant 
through a 0.2 um PTFE 
syringe filter / Standard 
addition with 5 µl of 100 ppb 
modifed 
quechers 
4 g of sample 
30 ml of solvent 
(with 25.2 mL 
of organic 
solvent)= 6.3 
meq= 4 g of 
sample 30 ml of 
solvent (with 
25.2 mL of 
organic solvent)* 
1 µl injection 
8 RIKILT SOP A1070 30 min blending, extraction 
solvent: 0,4 % Formic acid in 
Methanol/Water (6/4) 
No 
concentration/ 
clean-up 
procedure 
40 mL to 4g 
sample, i.e. 
solvent to 
Sample ratio 
=10 
meq: (40/4) x 
0.002 = 0.0002 
9 The method is based on LC-
MS/MS detection 
Blending extraction; solvent: 
water:methanol 2:3 v/v 
followed by centrifugation at 
4000 rpm 
Dilution and 
shoot. The 
supernatant 
was diluted 10 
times, for a 
total dilution 
1:50 w/v 
1:5 w/v meq = 0.0008 
10 This is our in-house method. SLE  2g sample and 
20 mL solvent 
 
11 Based upon a paper by Akira 
Namera (Springer-Verlag Berlin 
2005 
Mix with NT 20 Kieselguhr 
and extract with 3x5mL of 
dichloromethane. Evaporate 
to dryness derivatise with 
BSTFA/TMCS 
Evaporate to 
dryness at 50oC 
and derivatise 
with 
BSTFA/TMCS 
15mL of 
dichloromethan
e to 0.5 g of 
sample 
10-100 ng 
(nanogram) 
12 Stefan Kittlaus, Julia Schimanke, 
Günther Kempe, Karl Speer  
Journal of Chromatography A, 
1283 (2013) 98-109 
30 min ACN:water dilute and 
shoot 
20 mL to 2.5 g 
sample 
0.0625 
13 Draft protocol given by EURL 
after registration for PT 
Solvent: 
methanol/water/formic acid 
39:60:1; "head over head" 
extraction for 1 hour 
dilute and 
shoot 
10 (2/20)*0.020 = 
0.002 
14 extraction with 0.05M H2SO4, 
centrifugation, supernatant pH 
adjustment to 9-10 with NH4OH, 
extraction with ethylacetate, 
EtOAc evaporation, dissolution, 
high-speed centrifugation, 
injection 
extraction by agitation 
(vortex 10s, overhead 
15min) and sonication 15 
min, 0.05M H2SO4 
pH adjustment 
to 9-10, LLE 
with EtOAc, 
evaporation of 
the EtoAc, 
dissolution and 
centrifugation 
20 mL to 2 g 0.002 
15 RIKILT SOP for TAs in cereals and 
cereal products, EFSA project 
30 minutes shaking. 
Extraction solvent 
methanol/water/formic acid 
solution (75/25/0.4 %) 
SPE clean-up 
using Strata X-
C cartridges 
4 g sample in 
40 ml extraction 
solvent 
4g/40ml, 10ml 
for SPE, made up 
in 0.5ml = 
2g/ml. Injection 
2ul meq=0.004 g 
16 Draft method which was sent 
from JRC. 
Vortex few seconds, shaking 
1 hour. Solvent 
methanol/water/formic acid 
39:60:1 
Dilute and 
shoot 
10 0.001 
17 QuEChERS 30 min QuEChERS 5/2 0.72 
18 SOP provided by the EC Joint 
Research Centre, IRMM, EURL 
Mycotoxins 
Extraction time: 1hour 
shaking, 1 min vortex, 
methanol/water/formic acid 
39/60/1 
extract, dilute 
and shoot. No 
clean up, just 
filter with 
0.45um 
membrane 
2g of sample, 
20 mL 
extraction 
solvent 
meq=(2/20)x 
0.010 
19 Jandric et al., Food Additives and 
Contaminants Vol 28 (9), 2011, 
1205-1219 
5 Minutes, centrifugation C18 10/2  
20 Jandric et al., Food Additives and 
Contaminants 28 (9) (2011) 
1205-1219 
 just dilute and 
inject 
2 g sample/20 
mL solvent 
0.2 
21      
  
34
22 In house developped method 60 min by shaking with a 
solution of ACN:H20=3:2 
dilute and 
shoot 
5:1 0.2 mg 
23 Mol et. al, Food Additives and 
Contaminants 28(10) (2011) 
1405-1423 
shaking dilute and 
shoot 
100 0.0000125 
24 Prüfmethode "Bestimmung von 
Tropanalkaloiden in 
Lebensmitteln mittels UPLC-
MS/MS", Hessisches Landeslabor, 
Seite 1-5, M 3.3.3.806.01 
30 min shaked, solvent: 60 
% methanol + 40 % water + 
0.4 % formic acid 
no 
concentration, 
no cleanup, 
PVDF-syringe-
filtered 
1.0 g sample + 
25 ml solvent 
5 µl 
25 IRMM method from EURL 
"Determination of tropane 
alkaloids in cereals and cereal 
products by LC-MS/MS" 
shaking in 
methanol/water/formic acid 
39/60/1 for 1 hour 
centrifugation, 
supernatant 
was used for 
analysis 
10 meq=(2/20)x 
0.010 
26 principle: tropanic and ergots 
alcaloids are extracted by buffer 
at pH=9 and purification with 
dispersive phase (Bondesil PSA) 
then the extracts are filtered and 
injected for analysis by LC-MS. 
Time extraction : 30 min., 
extraction solid-liquid with 
mechanical rotation and 
centrifugation (4000 g). 
Solvent composition: 
acetonitrile-ammonium 
carbonate (84/16 v/v) 
Purification with 
Bondesil PSA 
and dilution 1/2 
with 
ammonium 
carbonate sol. 
(200 mg/L) 
Sample mass : 
5 g and volume 
solvent 
extraction: 25 
mL 
=2 mg injected 
(5/25 
x1/2x0.020) 
27 In house method based on 
modified QuEChERS procedure. 
Addition of internal standard was 
used for detection, quantification 
and recovery by LC-MS/MS. 
Vortex-mixing 3x2minutes, 
automatic shaker for 2 
hours; 10 mL 0.5% Formic 
acid in water:acetonitrile. 
50:50 (v:v) 
QuEChERS 
(MgSO4+NaCl), 
dSPE 
(MgSO4+PSA) 
4  (10 mL:2.5 
g) 
10 
28 EURL method 2g with 
methanol/water/formic acid 
39:60:1 / shaker for 1 hour / 
centrifuge and inject 
just dilute 10 0,002 
29 Modified after Jandric et al., FAC, 
28 (2011)1205-19. 
extraction time: 10 min, 
vortex/shaking; water, 0,5% 
HCOOH/ACN (1/3) 
QuEChERS 20 mL/5 g 5 mg 
30 For this proficiency test we used 
the Method from the EURL 
Mycotoxins. Before we used 
QuEChERS 
60 minutes on a shaker no 2 g on 20 ml 
extraction 
solvent 
0.001 
31 Deutsche Lebensmittelrundschau, 
Oktober 2015 page 418 
30 minutes (methanol/water 
60/40%) 
filtration 
Chromafil Xtra 
PA 0.45 um 
10 7.6 mg 
32 QuEChERS: Extraction for dry 
samples (extract 1) as 
Wheatflour: §64 LFGB L 00.00 - 
115; EN 15662 
a: 4 g of sample + 10 ml 
water, blend with vortex 
mixer, let soak for 5 min  /  
b: add 4 ml ACN + Internal 
Standard (Pririmicarb-D6)  /  
c: shake vigorously, 15 min 
overhead shaker, 30 min 
freezer, add first salt 
composite / d: centrifuge for 
5 min /  e: use 1 ml of the 
ACN-phase /  f: dilute 
extract: 1+1 with MeOH, 
inject for LC-MSMS analysis 
QuEChERS 1:1 meq=(4/4)*(1/2
)*0.001 = 
0.0005 
33 Adamse, P. u. H.P. Van Egmond 
(2010): Tropane alkaloids in 
food, RIKILT - Institute of Food 
Safety, Report 2010.011 
methanol/water/formic acid 
(60+40+0.4) / 30 min 
shaking 
Dilute and 
Shoot 
sample mass: 2 
g, solvent 
volume: 20 ml 
0.2 mg 
34 Adamse, P; H. P. Van Egmond 
(2010): Tropane alkaloids in 
food, RIKILT - Institute of Fodd 
Safety, Report 2010.011 
extraction time: 30 sec / 
Ultraturax  MeOH (600ml) / 
H2O (400ml) / formic acid 
(4ml)  / Ultraturax solvent 
composition: MeOH/H2O 
centrifugation / 
filtration 0.2µm 
10 (2.5/25) x (1/5) 
x 0.010 = 5 mg 
35 2.5g homogenized sample;  add 
25 ml extraction-solvent; 
blending for 30 min.; 
centrifugation for 10 min. 4400 
rpm; Filtration with syringe filter 
0.2µm; dilution 1/5 with water; 
5µl injection to LC-MS/MS 
Blending for 30 Min.; 
extraction-solvent:  MeOH 
600ml + Water 400ml + 
Formid acid 4 ml 
Filtration and 
dilute 
2.5 g/25 mL 2.5 g/25 mL; 
Dilution 1/5; Inj. 
5µl  = 0.1 mg 
36 Analysed as per method supplied As per method supplied As per method 
supplied 
As per method 
supplied 
As per method 
supplied 
37 acid extraction, SPE, drying of 
sample, reconstitution and LC-
MS/MS 
30 min, 0.05 M H2SO4,  
sonication 
SPE 40 ml solvent 
for 2 g sample 
mass 
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38 in house method: Hessisches 
Landeslabor / "Bestimmung von 
Tropanalkaloiden in 
Lebensmitteln mittels UPLC-
MS/MS" (M 3.3.3.806.01) 
shaking 30 min 
methanol/water 60:40 with 
0.4% formic acid 
dilute and 
shoot 
1.25 g sample 
in 12.5 mL 
solvent 
0.2 mg 
39 EURL method 1 hour shaking, 
methanol/water/formic acid 
(39/60/1, v/v/v) 
no 
concentration 
or cleanup 
20 mL solvent 
2g sample mass 
1 mg 
40 RIKILT SOP A1070 (modified) 15 min, blending, methanol / 
water (60:40) + formic acid 
(0.4 %) 
Dilute and 
Shoot 
4 0.002 
41 EURL method provided was used extraction time 1.5 hours / 
60:39:1 water: 
methanol:formic acid (see 
EURL method provided) 
None 2 gram sample 
and 20 mL 
solvent 
meq=(2/20)x 
0.002 
42 In house method (own 
development) 
60% methanol with 0.4% 
formic acid, 45 min, 
sonication 
dilute and 
shoot 
2 g in 20 mL 0.025 mg 
44 BfR-PA-2.0 n.s. n.s. n.s. 1g sample, 20 ml 
solvent, SPE with 
entire extract, 
reconst. in 1 ml. 
Injection of 5 µl 
45 Food Additives and 
Contaminants, 28(9) ( 2011), 
1205-1219 
2 min, shaking, ACN/water 
75/25 with 0.5% formic acid 
LLE with 
SupelQUE, 
Order No. 
55227-U, 
Sigma Aldrich 
20 mL / 2.5 g 1.33 mg 
46 RIKILT SOP A1070 Determination 
of ergot and tropane alkaloids in 
animal feed by LC-MS/MS. 
Special application for cereal-
based foods 
30 min extraction (head-
over-head) with 
methanol/water/formic acid 
60/40/0.4 
Clean up by 
ultrafiltration 
over 30 kD UF 
filter. 
2 g sample with 
20 mL 
extraction 
solvent 
5 ul injection: 
(2/20)x0.005 = 
0.5 ug 
47 In-house developed method 15 min extraction by 
sonication in methanol : 
acetonitrile 1:1 [v:v] 
SPE: ion 
exchange 
(SCX) 
1 g sample 10 
mL solvent 
meq = 
(1/10)*(5/1) * 
0.010 = 5 mg 
49 EURL Draft SOP Shake 1h, Extraction solvent 
MeOH:H2O:Formic Acid 
(39:60:1) 
Dilute and 
shoot 
10 0.001mg 
50 Jandric et al. (2011); Food 
Additives and Contaminants 28 
(9) 1205-1219 
30 min, shaking, methanol + 
water (60+40) + 0.4 % 
formic acid 
dilution 2.5 g with 25 ml 
solvent 
0.5 mg 
51 Method was validated in-house 30 min. shaking with 
extraction solvent: 
methanol/water/formic acid 
sol. (60/40/0,4 % HCOOH) 
Dilute and 
shoot 
Volume of 
solvent: 10 ml 
Sample mass: 1 
g 
meq=0.0002 
52 EURL method - Determination of 
tropane alkaloids in cereals and 
cereal products by LC-MS/MS 
1h, shaker, 
methanol/water/formic acid 
(39:60:1, v/v) 
dilute and 
shoot 
10 (2 g in 20 
mL) 
 
 
 
Lab Q.10 
Type of separation 
Q.11 
Type of detecton 
Q.12 
Transitions, ratio and CID 
Q.22 
Calibrant 
Q.23 
* 
2 ZORBAX Extend C18 4.6x100 mm, 
3.5µm 
Agilent 6460 Triple Quad 
LC/MS; ESI+; Capilary 
voltage 3000V, 
dessolvation temp. 
370°C 
Atropine: 290.2->124.1; 290.2 -
>103 / Scopolamine:  304.2-
>156.1; 304.2-->138.1 
Our own MMC 
4 Waters, ACQUITY UPLC BEH C18; 150 x 
2.1 mm; 1.7 µm  / A: 0.1 % formic acid 
in water  B: 0.1 %formic acid in 
acetonitrile / column temp.: 30 °C / flow 
rate: 0.200 ml / min / inj. vol.:  10 µl 
Agilent 6460 QQQ; ESI 
positive / Capillary 
voltage:  3000 V 
Atropine: 290 < 124   CE 30 eV / 
290 < 93  CE 30 eV 
Atropine-D3: 293 < 127  CE 20 
eV /     293 < 96  CE 30 eV 
Scopolamine: 304 < 156  CE 10 
eV /     304 < 138  CE 18 eV 
Scopolamine-D3: 307 < 159  CE 
10 eV / 307 < 141  CE 18 eV  
Our own SPS 
5 Phenomenex. Gemini, C18, 150 mm x 
2.0 mm, 5 µm, Ammonium carbonate 
400 mg/l pH 10.5, Acetonitrile, gradient 
flow 200 µl/min, 30°C, 10 µl 
AB Sciex 5500, ESI 
positive, 5500 V, 550°C 
Atrop: Q 290 C 124 CID 31 V 
Atrop D3 Q 293 C 127 CID 33V 
Scop Q 304 C 127 CID 27 
Our own SPS 
6 Column: Zorbax Eclipse Plus C18 
(2.1x100 mm; 1.8 µm) ; Mobile phase: 
HPLC-Agilent 1290 
INFINITY and MS-6495 
Atropine 1= 290.2>124.2 (30V)   
Atropine 2: 290.2>93.1 (40V) 
Supplied 
along 
SPS 
  
36
Water (5mM Ammonium formate, 0.1% 
formic acid)/MeOH (5mM Ammonium 
formate, 0.1% formic acid) / Flow=0.3 
ml/min; T= 50ºC ; injection volume: 2µl 
Triple Quad, positive 
mode, 3500 V, T. 
dessolvation= 350ºC 
Scopolamine 1= 304.1>138.1 
(30V)   Scopolamine 2: 
304.1>156.3 (20V) 
with the 
PT 
samples 
7 Reversed phase: Waters Kinetex EVO 
C18 column  1.7µm 100 x 2.1 mm / 
40°C / 1 µl injection / 0.5 mL/min of 
mobile phase: ACN-H20 with ammoniak 
buffer / 40°C  
HPLC_MS/MS XEVO TQS 
WATERS / ESI+ / CV: 1 
kv / Desolv temp: 450 
°C 
Atropine Q124.0 (25V) - C93.0 
(30V) Scopolamine Q138.0 (20V) 
- C156.0 (15V) 
Supplied 
along 
with the 
PT 
samples 
SPS 
8 Column: Waters XBridge C18 (75mm x 
3mm, 2.5um) / Mobile Phase: A: 6mM 
NH4OH B: 6mM NH4OH in Methanol / 
Column Temperature: 40C / Flow rate: 
0.4 mL/min / Injection Volume: 2uL 
LC-MS/MS: Agilent 1290 
LC/Agilent 6490 QQQ, 
ESI+, Capillary Voltage 
3000V, Gas Temperature 
180C 
Atropine: Primary Transition (Q) 
290/124, CID 29V, Secondary 
Transition (C) 290/93, CID 37V,  
 
Scopolamine: Primary Transition 
(Q) 304/138, CID 29V, Secondary 
Transition (C) 304/156, CID 17 
Supplied 
along 
with the 
PT 
samples 
MMC 
9 The separation was performed on a RP-
C18 Kinetex column (2.6µ, 100A; 
100x2.10 mm; Phenomenex, Torrance, 
CA, USA). Flow rate was 0.35 mL/min, 
column oven temperature was at 40°C, 
sample temperature was at 20°C and the 
injection volume was 4 uL 
UHPLC Dionex Ultimate 
coupled with a triple 
quadrupole mass 
spectrometer TSQ 
Vantage with an ESI 
interface. Positive 
ionization mode. Spray 
voltage 3500 V, capillary 
temp. 270 °C. Vaporizer 
temp. 250 °C, sheath 
gas flow 50 units, 
auxiliary gas flow  15 
units 
Multiple reaction monitoring 
(MRM) with the following 
transitions: 
290 =>93 (CE = 33 eV) and 
290=>124 (CE = 25 eV) for 
atropine  
 
304==>103 (CE = 35 eV), 304 
=>138 (CE = 19 eV) and 304 
=>156 (CE = 16 eV) for 
scopolamine. 
Supplied 
along 
with the 
PT 
samples 
SPS 
10  LC-MS-MS atropine: 290/93, 290/124 
scopolamine: 304/138, 304/156 
atropine D3: 293/127 
Our own MMC 
11 HP5 Msi 30mx 0.25x0.25 GC-MS Deuterated atropine  
12 YMC-Pack Diol 2.1 x 100 mm; 5 µm; 120 
Å; Phenomenex Synergi Fusion -RP 2 x 
100 mm; 2.5 µm; 100 Å 
LC-LC-MSMS (2-
dimensional) ESI pos 
Atropine 290/124 +290/93 
Scopolamine 305/138+305/156 
Our own MMC 
13 Column: Supelco Ascentis Expres F5, 10 
cm x 2.1 mm; 2.7 um MF: A - 0,1% 
FA/water, B - 0,1% FA/acetonitrile; flow 
rate: 0.3 ml/min; column temperature: 
40 oC; Injection volume: 20 ul 
LC-QQQ Agilent 6460, 
ESI + JetStream; Gas 
Temp 325°C; Gas Flow 
10 L/min; Nebulizer: 25 
psi; Sheath Gas Temp 
400°C; Sheath Gas Flow 
11 L/min; Capillary 
Voltage 3000 V; delta 
EMV 600 
Scoplolamin Q: 304.2->156 (10); 
q 304,2->138 (18); 
Atropin Q 290,3->124.1 (20); q 
290.3-->93.1 (30) 
Supplied 
along 
with the 
PT 
samples 
MMC 
14 ZIC-HILIC (SeQuant Merck) 
150mm*2,1mm*5µm and precolumn / 
mobile phase (gradient): starting 10% 
(5% ACN 95% 10mM ammonium 
actetate) end to 80% (95% ACN 5% 
10mM ammonium actetate) in 10 min, 
30°C, 0.3mL/min, 10µL 
LC-MS/MS (API 4000 
QTrap), ESI+, 
Declustering potential: 
76V (atropine), 51V 
(scopolamine); cell exit 
potential  6V (atropine 
and scopolamine), 
Atropine: Q 290.1- 124.1 C 290.1 
– 93.1, collision energy 35eV 
Scopolamine: Q 304.1 – 138.2  C 
304.1 – 156.2, collision energy 
31eV 
Supplied 
along 
with the 
PT 
samples 
 
15 Column: Waters UPLC BEH C18 150 x 
2.1 mm, 1.7 µm.  
Column temperature: 50 oC. 
Mobile phase A: 6.65 mM ammonia in 
water, Mobile phase B: 1.30 mM 
ammonia in acetonitrile, Flow: 0.4 
ml/min, Injection volume: 2 µl, Total run 
time: 15 min, Gradient (linear): 100 % A 
for 2 min and then goes to 60 % B at 12 
min.  Then stepped up to 99 % B for a 3 
min, equilibrate for 5 min. 
A: 10 mM ammonium carbonate in water 
at pH 10,  B: acetonitrile. 
Waters Acquity UPLC 
with Waters Xevo TQ-S 
ESI+, capillary voltage 2 
kV and desolvation 
temperature 500 oC 
Atropine 290>124, CE 20eV, 
290>93 CE = 25 eV 
Scopolomine 304>138, CE 20eV,   
304>103 CE = 30 eV 
Our own SPS 
16 Column: Ascentis Express F5, Supelco, 
100mm x 2.1 mm, 2.7 µm 
Mobile phase: A 0.1% Formic acid in 
water, B 0.1% Formic acid in acetonitrile 
0 min 10% B -> 1 min 20% B -> 10 min 
90% B 
Flow rate: 0.3 ml/min 
Temperature: 40 °C  
Injection volume: 10 µl 
LC-MS/MS: Shimadzu 
LCMS-8050 / ESI+ / 
Interface voltage: 4 kV / 
Desolvation temperature: 
150 °C / Interface 
temperature: 300 °C 
Atropine: Q 290.00 ->124.20, 
CID 24 / C 290.00 -> 93.05, CID 
30 
D5-atropine: Q 295.00 ->124.15, 
CID 25 / C 295.00 -> 93.05, CID 
30 
Scopolamine: Q 304.10 -
>138.15, CID 21 / C 304.10 -> 
156,10, CID 17 
13C D3-scopolamine: Q 308.10 -
Supplied 
along 
with the 
PT 
samples 
MMC 
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>142.20, CID 21 / C 308.10 -> 
160,15, CID 18 
17 Acquity UPLC BEH Phenyl; 2.1X100 mm; 
1,7µm 50 ° C; 0.4ml/min; 2µl 
LC-MS/MS; ESI:  550°C; 
0.3CV 
Atropine: 290.12 >124.7; 290.12 
>93.08  
Scopolamine: 304.11>138.06 ; 
304.11>156.07 
Supplied 
along 
with the 
PT 
samples 
SPS 
18 F5 column, 10cm x 2.1mm, 2.7um 
particle size, mob. phase water+0.1%FA 
and MeOH+0.1%FA gradient, temp. 
40oC, flow rate 0.3mL/min, inj. vol. 10uL 
LC-MSMS, Thermo 
Finnigan TSQ Quantum, 
ESI+, Spray Voltage 
3400V, Cap. Temp. 
325oC 
Atropine Q:124.2 (22V) C:93.1 
(31V) 
Scopolamine Q:156.18 (16V) 
C:138.14 (22V) 
Supplied 
along 
with the 
PT 
samples 
SPS 
19 n.A. LC-MS/MS Applied 
Biosystems, API 5500 
290/128; 304/138 Our own SPS 
20 Acguity BEH C18 , 1,7 um, 2.1 x 50 mm Waters UPLC-MSMS, 
ESI+, capillary 2.5 kV, 
desolvation temperature 
450°C, source 120°C 
Atropine 290/124 (20 V)  
Scopolamine 304/156 (35 V) 
304/136 (35 V) 
Our own SPS 
21 Waters UPLC BEH C18 100 x 1 mm, 1.7 
µm 
Mobile phase A: 6,65 mM ammonium 
hydroxyde : H2O 
Mobile phase B: 1.3 mM ammonium 
hydroxyde : ACN 
Flow: 0.15 ml/min. (gradient elution 
between A&B) / Injection volume: 2 µl. 
Waters Acquity UPLC-
TQD, Source temp.: 
135ºC / Desolvation gas 
temp.: 400ºC / 
Desolvation gas flow: 
400 L/h / Cone gas flow: 
150 L/h. 
Atropine 289.9> 124.1   > 91.0 
AtropineDd3 293.2> 127.0    >  
93.0 
Scopolamine 303.9 >138.1 > 
156.0 
Scopolamine-d3 307.2 >141.0 > 
159.0 
  
22 Column ZORBAX SB-C18 (50 mm, ID 2.1 
mm, particle size 1.8  micron). Phase A: 
0.1% formic acid in H2O. Phase B: 0.1% 
formic acid in acetonitrile. Temperature 
40°C. Flow rate 0.4 mL/min. Injection 
volume 10 uL. 
Gradient elution - from 95% A to 95% B 
in 5 min, followed by a 1 min isocratic 
step at 95% B. The column was 
reconditioned at 95% A for 1.5 min. 
LC-MS/MS (LC Agilent 
1290; MS/MS detector 
Agilent 6430). ESI+. 
Capillary voltage 4000 V. 
Desolvation temp. 
300°C. Gas temperature 
300°C. Gas flow 10 
L/min. Nebulizer 35 psi 
Scopolamine: Q (304.16->156.1, 
collision energy 9V), C (304.16-
>138.1, collision energy 13V). 
Atropine: Q (290.18->124.1, 
collision energy 21V), C (290.18-
>103.1, collision energy 40V) 
Supplied 
along 
with the 
PT 
samples 
SPS 
23 RP18plus, Macherey-Nagel Nucleoshell, 
100mm x 2 mm, 2.7 µm; 30 °C, 0.3 
ml/min, 5 µl 
Agilent 6490, ESI, 4000, Atropine 290.2/124.1 (CE 28V), 
Atropine 290.2/77 (CE 60 V) 
Atropine 290.2/93 (CE 37 V) 
Scopolamine 304.2/ 103 (CE 49 
V), Scopolamine 304.2/138 (CE 
21 V),  Scopolamine 304.2/156 
(CE 17 V) 
Supplied 
along 
with the 
PT 
samples 
SPS 
24 Gemini C18, 3µ, 100x3mm / mobile 
phase: A: 0.1 % Formic acid in Water,  
B: 0.1 % Formic acid in Methanol / 
Temp.: 40 °C; Flow: 0.2 ml/min 
LC-MS/MS, ABSCIEX 
5500 QTRAP, Esi 
positive, Ion Spray 
Voltage: 4000 V; Temp.: 
500 °C 
Atropine: Precursor 290, 
Transition 1: 124; Transition 2: 
93; CE: 33 / 39      
Scopolamine: Precursor 304, 
Transition 1: 156; Transition 2: 
103; CE: 23 / 55 
Supplied 
along 
with the 
PT 
samples 
SPS 
25 Ascentis Express F5 100mmx2.1mm 2.7 
µm; water/acetonitrile with 0.1 % formic 
acid; 40 °C; 0.3 ml/min; 10 µL injection 
volume 
LC-MS, ABSciex 5500 
QTrap, ESI positive, IS 
2500 V, TEM 200 °C 
Atropine: Q 290 ->124 CE 33 V, C 
290 -> 93 CE 39 V 
Scopolamine: Q 304 ->138 CE 29 
V, C 304 -> 156 CE 25 V 
Supplied 
along 
with the 
PT 
samples 
SPS 
26 X Bridge Column C18, 150 mm x 3 mm, 
5 µm  / Mobile phase:  ACN/Ammonium 
carbonate aq. (from 10/90  to 80/20 ) / 
Column temp.: 40°C  / Flow rate: 0.4 
mL/min / volume inj.: 20 µL  
Waters Xevo TQMS 
Acquity HPLC; ESI+; 
capillary voltage: 3,0 kV        
Dessolvatation temp.: 
500°C   
Atropine  Q:290>92.9 CID:32 - 
C:290>124.1 CID:28 
Scopolamine Q:304.1>130.03    
CID:22 - C:304.1>156.1 CID: 16 
Secondary transition: atropine 
124.09, Scopolamine: 156.07 
Our own MMC 
27 Column: XBridge Amide, Waters, 
150x2.1 mm, particle size 3.5 um, 
temperature 30 C, flow rate 0.2 mL/min, 
injection volume 20 uL. Mobile phase: 
water and acetonitrile. 
LC-MS/MS, Thermo 
Finnigan type TSQ 
Quantum ULTRA EMR, 
ESI (+); Spray voltage 
4000 V; Dessolvation 
temp.: 200 C, Capillary 
temp. 325 C. 
290.030>93.100 (31V); 
290.030>124.200 (22V); 
295.120>93.100 (31V); 
295.120>124.170 (24V); 
304.100>138.140 (22V); 
304.100>156.180 (22V); 
304.100>182.200 (20V); 
308.100>142.160 (22V); 
308.100>160.200 (22V); 
Supplied 
along 
with the 
PT 
samples 
SPS 
28 Ascentis Express F5 10cm x 2.1 mm 2.7 
µm particle size / Column 40 °C, 20 µL 
inject, flow rate 0.250 mL / Mobile fase 
A: ultrapure water 0.1% formic acid / 
Mobile fase B: ACN 0.1% formic acid 
LC-MS/MS Quattro 
Ultima PT Waters / ESI + 
/ capillary voltage 3500 
V, dessolvation 
temperature: 350 °C 
Atropine: 290.1>124.1   
290.1>93.1 
Scopolamine 304.1>138.0  
304.1>156.0 
Supplied 
along 
with the 
PT 
samples 
SPS 
29 Kinetex 2,6 u Biphenyl, 150x2.1 mm, LC/MS, Micromass Atropin:  290.2 > 124.3 (Q); Supplied MMC 
  
38
MP-A: water 0.1% HCOOH; MP-B: 47.5% 
MeOH, 47.5%ACN, 5%water, 0.1% 
HCOOH, 35 0C, 0.1 ml/min, 10uL. 
Ultima, ESI+, 3.5 kV; 
400 oC, 
290.2 > 93.2 (C), 25V 
Scopolamine: 304.3 > 138.1 (Q); 
304.3 > 156.1 (C), 20V 
along 
with the 
PT 
samples 
30 Supelco Ascentis Express F5  / 10cm x 
2.1mm, 2.7µm   / mobile phase A: 98% 
Water + 2% Acetonitrile + 0,1% formic 
acid   /  mobile phase B: 100% 
Acetonitrile + 0,1% formic acid 
LC-MS/MS (API 4000 
QTRAP, Siex) / ESI pos; 
CUR 30, CAD medium, 
Ion spray voltage 5500, 
TEM 500, GS1 40, GS2 
60 
Scopolamine Q 304.0 / 138.0     
DP 71     CE 27  /  C  304.0 / 
155.9     DP 71     CE 23 
Atropine: Q  290.0 / 124.0     DP 
126     CE 33  /  C 290.0 / 93.0     
DP 126     CE 41 
Our own MMC 
31 BEH C18 50 mm 1.7 um Waters Acquity TQD Atropine: 290.1>93.1; 
290.1>124.1  Scopolamine: 
304>138.1; 304>156.0 
Supplied 
along 
with the 
PT 
samples 
SPS 
32 Kinetex C18 (Phenomenex), 
2.1*100mm, 2.6µm, 100A; A: 
H2O+5mM NH4-Formiate, B: 
MeOH+5mM NH4-Formiate; Flow: 0.4 
ml/min, 20°C, Injection: 1µl 
Agilent 1290-6495; LC-
MSMS Triplequad, ESI 
pos, D EMV(+): 400V, 
Capillary Voltage: 3500 
V, Gas Temp: 120°C, 
Sheath Gas: 375°C 
Atropine: 290.3-124.1 (CE:24, 
CAV:1); 250.3-103.1 (CE:51, 
CAV:1)    
Scopolamine: 304.2-156.2 
(CE:19, CAV:1); 304.2-138.1 
(CE: 28, CAV:0); 304.2-103 (CE: 
51, CAV:1) 
Our own MMC 
33 Waters Acquity BEH C18 1.7 µm, 2.1 x 
50 mm  / mobile phase A: 0.1 % formic 
acid in water  /  mobile phase B: 0.1 % 
formic acid in methanol  /  flow rate: 0.3 
ml/min  /  temperature: 40 °C  /  
injection volume: 10 µl 
LC-MSMS: Waters 
Acquity Xevo TQD, ESI+ 
Scopolamine: 304 -> 138 (Q); 
304 -> 103 (C) 
Atropine: 290 -> 124 (Q); 290 -> 
93 (C) 
Our own SPS 
34 UPLC C18, 1.7 µm, 2.1 x 50 mm 
precolumn, mobile phase: A: 0.1 % 
formic acid/ in water; B: 0.1 % formic 
acid in MeOH, temp.: 40 °C, flow: 0.3 
ml/min, injection volume: 10 µl 
LC-MS/MS, ES+, 
capillary voltage 0,3 kV, 
dessolvation temp.: 
550°C 
Atropine: 290.25 -> 93; 290.25-
> 124.1; 
Scopolamine: 304.2->156.1; 
304.2->138.1 
Our own MMC 
35 Kinetex C18 2.6µ 100A; 100 mm id x 2.1 
mm; particle size: 2.6 µm; Eluent A: 
Water + 0.1% Formic acid; Eluent B: 
MeOH + 0.1% Formic acid; Gradient 
from 10% B at 0 Min. to 90% B at 10 
Min; Temperature 35°C; Injection 
volume: 5µl 
Sciex QTrap5500; ESI 
pos.; 5500 Volts; 650°C 
Atropine: 290.078 -> 124.0; CE 
33 ; 290.078 -> 93.0; CE 39 
Scopolamine:  304.062 -> 138.1; 
CE 27 ; 304.062 -> 156.1; CE 23 
Supplied 
along 
with the 
PT 
samples 
MMC 
36 As per method supplied. Gradient time 
reduced to 8 mins as we used UPLC. (All 
time intervals in method supplied divided 
by 2) 
Quattro Ultima As per method supplied  CID 
varied slightly 
Supplied 
along 
with the 
PT 
samples 
SPS 
37 C18 column, 2.1 x 150 mm, 1.8 Micron; 
mobile phases: H2O (A) and MeOH (B) 
both containing formic acid and 
ammonium formiate, injection 1 µl, flow 
rate 0.5 ml/min 
LC-MS/MS, ESI mode 
(neg.) 
Atropine: Q 290.2 > 124 (CE = 
21); C 290.2 > 93 (CE = 29) 
Scopolamine: Q 304.2 > 156 (CE 
= 9); C 304.2 > 138 (CE = 21) 
 MMC 
38 Agilent Zorbax Eclipse Plus C18 RRHD 
2.1x100 mm 1.8 µm methanol/water 
20:80 with 0.1% formic acid 
Agilent 6460 Triple 
Quadrupole, ESI+, 300°C 
Gas temperature 
Atropine Prim 290.2 > 124.0 Sec 
290.2 > 93.0 / Atr.-d5 
295.3>124.1 
Scopolamine Prim 304.1>138.1    
Sec. 304.1>156.1  /   Scop 
d3,C13 308.2>142.0 
Supplied 
along 
with the 
PT 
samples 
MMC 
39 Phenomenex 5u Luna Phenyl Hexyl 
150*2mm, Eluent A: 0.1% formic acid in 
water, Eluent B:Methanol, Temperature 
40°C, Injection Volume 10 µL / Gradient: 
1min - 10% B, 2min - 10% B, 10min - 
80% B, 12min - 80% B, 13 min - 10%B, 
15min - 10% B, Temperature: 40°C, 
Injection Volume 10 µL  
LC MS: AB Sciex API 
4000 QTrap, Scheduled 
MRM ESI+, Capillary 
Voltage 3500, 
Temperature 600 oC 
Atropine: Quantifier: 290/124.1 
CE 38, Qualifier: 290/93.1 CE 75 
Scopolamine Quantifier: 
304.17/138.2 CE 35, Qualifier 
304.17/156.2 CE 23 
Supplied 
along 
with the 
PT 
samples 
SPS 
40 XBridge C18, 5µm, 3.0 x 150 mm, 
Waters; mobile phase:: water / 
acetonitrile, 6 mM NH4OH; 40ºC: 0.4 
ml/min; 10µl 
LC-MS/MS; Waters TQ; 
ES+; 2 kV; 400 ºC 
Atropine: 290.16 > 124.24 (25 
eV); 290.16 > 93.17 (25 eV); 
Scopolamine: 304.21 > 138.25 
(30 eV); 304.21 > 156.25 (20 
eV) 
Supplied 
along 
with the 
PT 
samples 
SPS 
41 Column: acquity UPLC HSS T3 1.8 um, 
2.1*100 mm / mobile phase Eluent A 
0.02% formic acid in water, Eluent B   
0.02% formic acid in acetonitrile. Flow 
rate 0.3 ml/min. Injection volume 2 uL. 
Temperature 40°C. 
LC-MS-MS, ESI+, 
capillary voltage 1.05 
KV, dessolvation 
temperature 600°C 
Atropine:290.1 to 124.1 / CID 
23eV ; 290.1 to 93.1 / CID 28 eV  
Scopolamine: 304.1 to 138 / CID 
20 eV ; 304.1 to 156 / CID 16 eV 
Our own SPS 
  
39
42 50 x 2.1 mm Kinetex C18, 2.6 µm, 
gradient: 0.2% formic acid in water and 
methanol, temperature 25°C, 0.3 
mL/min, 10 µL 
LC-MS/MS, API 5500 
(Sciex), ESI positive 
Atropine Q 290.0 -> 124.0, CE 
33; C 290.0 -> 93.0, CE 45 
Scopolamine Q 304.1 -> 138.0, 
CE 31;  304.1 -> 103.1; CE  50 
Our own SPS 
44 n.s. LC-MS/MS (Sciex API 
5500) 
n.s. Our own SPS 
45 Macherey-Nagel, Nucleoshell RP 
18plus,150 x 2 mm, particle diameter: 
2.7um; eluent A: 315 mg ammonium 
formate + 1 mL formic acid + 1 L water; 
eluent B: 315 mg ammonium formate + 
1mL formic acid + 1 L methanol; 40°C; 
inj. vol. 1 µl 
LC-MS/MS; 5500 Triple 
Quad (SCIEX), ESI 
positive, 4500 V, 550°C 
Atropine: 290 ->124 (Q), CID 
41V; 290 ->93 (C), CID 43V; 
Scopolamine: 304 ->138 (Q), CID 
31V, 304 ->156 (C), CID 23V 
Supplied 
along 
with the 
PT 
samples 
SPS 
46 Waters UPLC BEH C18 150x2.1 mm, 1.7 
um. mobile phase A: 10 mM ammonium 
carbonate pH 10.0, mobile phase B: 
acetonitrile. 400 ul/min, 15 min run 
time, 50oC, 5 ul injection 
Waters Xevo TQ-S LC-
MS/MS. pos ESI, cap V: 
3.0kV, cone V: 30V, 
Desolvation gas T: 
600oC, cone T: 150oC, 
collission gas: Argon, 
4.2x10-3 mbar 
Atropine: Q = 290.2>124.0, CE: 
20eV, C = 290.2>93.0, CE: 25eV  
/ Scopolamine: Q = 304.2>138.0, 
CE: 20eV; C = 304.2>103.0, CE: 
35eV 
Our own MMC 
47 Waters Acquity BEH 150 x 2.1 mm, 1.7 
µm / Mobile phase A: 5mM ammonium 
formiate in water + 0,1% formic acid 
/Mobile phase B: 5mM ammonium 
formiate in methanol + 0,1% formic acid 
/ Temp.:  40°C / Flowrate: 0.3 ml/min 
/injection vol: 10µL 
LC-MS² AbSciex 5500 in 
ESI+ mode  / Capillary 
voltage 5000V  / Temp 
300°C  / IS: 4500V  /  
Source Temp: 300°C 
Q(Atropine) = 290.2 / 124 CE = 
33eV  C(Atropine) = 290.2 / 93.0  
CE = 49 eV 
Q(Scopolamine) = 304.2 / 138.1  
CE = 29 eV C(Scopolamine) = 
304.2 / 156.1  CE =  23 eV   CID 
= CE in AbSciex MS² 
Supplied 
along 
with the 
PT 
samples 
SPS 
49 Ascentis Expess F5, 10cmx2.1mm, 
2.7um   /  H2O+0.1% Formic acid, 
ACN+0.1% Formic acid gradient.  / 
40ºC, 0.3ml/min, 10uL injection volumn. 
LC-MS/MS, Waters Xevo 
TQ-S, ESI mode, capilary 
voltage: 3.5kV, 
Dessolvation T:280C 
Atropine : Q: 290.16 > 124.10  
CID: 24eV , C: 290.16 > 93.05 , 
CID: 28eV 
Scopolamine : Q: 304.16 > 
138.10  CID: 22eV , C: 304.16 > 
156.10 , CID: 15eV 
Supplied 
along 
with the 
PT 
samples 
SPS 
50 Waters Xselect HSS T3, 2.5 µm, 2.1 x 
100 mm, Methanol, Water 1 % Formic 
Acid, 350 µl/min, 35 °C, 5 µl 
LC-MS/MS, SCIEX QTRAP 
5500, ESI pos, 400 °C, 
5500 V 
Scopolamine 304 >138.2; DP 66 
V, CE 27 V  304> 156. DP 66 V, 
CE 23 V 
Atropine 290 > 124.1  DP 96 V, 
CE 33 V; 290 > 92.9  DP 96 V, CE 
39 V 
Supplied 
along 
with the 
PT 
samples 
SPS 
51 Column - Acquity HSS T3 C18 (100 x 2.1 
mm , 1.8 µm), Waters; Mobile phase A: 
0.1 % HCOOH + 5 mM ammonium 
formate in water; Mobile phase B: 0.1 % 
HCOOH + 5 mM ammonium formate in 
methanol; Column temperature: 40ºC; 
Flow: 0.4 ml/min.; Injection volume: 2 
µl 
Agilent 6495 Triple Quad 
LC/MS, ESI+, coupled 
with a Agilent 1290 
Infinity II UPLC. Gas 
Temp: 200ºC; Gas Flow: 
12 L/min; Nebulizer: 20 
psi; Sheath Gas Temp: 
400ºC; Sheath Gas Flow: 
11 L/min; Capillary: 
3500 V; Nozzle Voltage: 
500 V; iFunnel 
parameters: High 
Pressure RF: 200 V, Low 
Pressure RF: 100 V 
Atropine Q: 290 ->124 (CE 24); 
C: 290->91 (CE 48), 290->93 
(CE 36); 
Scopolamine Q: 304->138 (CE 
20); C: 304->103 (CE 44), 304-
>156 (CE 16) 
Our own MMC 
52 Supelco ascentis express F5. 
10cmX2.1mm, 2.7um 
LC-MS. Waters quattro 
premier, ESI+, 3.5KV, 
280°C 
Atropine: Q=290.1-124.1 (CID 
22eV); C=290.1- 93.1 (CID 24eV) 
Supplied 
along 
with the 
PT 
samples 
SPS 
* Approach for calibration: MMC – matrix-matched calibration / SPS – standards in pure solvent 
 
 
Lab Q.15 
Strategy used for 
LOD/LOQs estimation 
Q.16 
Performance 
parameters SCOP 
Q.17 
Performance 
parameters ATROP 
Q.18 
Recovery 
calculation 
Q.26 
Results 
reported 
2 Low level spiking R2=0.99985549 R2=0.99996418 spiking matrix NOT CORRECTED 
for recoveries 
4 S/N 3:1 qualifier for LOD, 
10:1 S/N LOQ qualifier 
R2 = 0.99942611 R2 = 0.99973123 internal standard NOT CORRECTED 
for recoveries 
5 DIN 32645 RSD 13 %, r=0.99960 RSD 20 %, r=0.99995 spiked matrix NOT CORRECTED 
for recoveries 
6 Low level spikes  RSD (average)=10 RSD (average)=19 %; Recovery calculation CORRECTED for 
  
40
%; r2=0.998 r2=0.9925 of the isotope-
labelled internal 
standard 
concentration spiked 
before extraction 
recoveries 
7 Lowest validated level = 
LOQ 
R2=0.998 / (conc-
RSD% n=3 days): 2.5 
ppb-4.31%/ 50 ppb-
5.66%/150 ppb-
11.65% 
R2 =0.988 (conc-
RSD% n=3 days) 2.5 
ppb-19.90%/ 50 pbb-
8.19%/150 ppb-
11.50% 
spiked matrix during 
validation of the 
method 
NOT CORRECTED 
for recoveries 
8 S/N ratio (3 and 10 resp.) 
from the lowest calibration 
point 
precision RSD 8%, 
correlation coefficient 
0.999 
precision RSD 2%, 
correlation coefficient 
0.999 
spiked matrix NOT CORRECTED 
for recoveries 
9 LOD and LOQ were 
determined by analysing 
blanks at low level spikes. 
RSD%: 5.2%; 
correlation coefficient 
0.995 
RSD%: 1.8%; 
correlation coefficient 
0.997 
Buckwheat matrix 
spiked at 5 ppb. 
RR% was 104% for 
atropine and 98% 
for scopolamine 
NOT CORRECTED 
for recoveries 
10     CORRECTED for 
recoveries 
11 Low level spikes and 
reagent blank results 
Insufficient data at 
this time. r2 0.999997 
Insufficient data at 
this time. r2 0.999260 
Spiked sample in 
presence of 
deuterated atropine 
 
12 10   spiked sample CORRECTED for 
recoveries 
13  R2 = 0.9969 R2 = 0.9989 spiked blank sample, 
whole analytical 
procedure 
CORRECTED for 
recoveries 
14 LOD S/N ratio 3 / LOQ S/N 
ratio 10 
RSD% 1-8%, standard 
addition curve: 0.9992 
RSD% 1-8%, standard 
addition curve: 0.9991 
spiked matrix NOT CORRECTED 
for recoveries 
15 LOQ - lowest calibration 
standard LOD - comparison 
of S/N in solvent std, then 
adjusted for background / 
baseline in matrix 
RSD%= 4-14% at 
1ug/kg, r =>0.95 
RSD%= 2-18% at 
1ug/kg, r=>0.95 
 CORRECTED for 
recoveries 
16 LOD S/N 3 
LOQ S/N 10 
r=0.9992, r2=0.9985 r= 0.9998, r2=0.9995 spiked sample 
matrix 
CORRECTED for 
recoveries 
17     CORRECTED for 
recoveries 
18 Parameters from the 
calibration curve 
R2=0.9969 R2=0.9972 spiked sample CORRECTED for 
recoveries 
19 Calibration Curve >0.999 >0.999 n.A. NOT CORRECTED 
for recoveries 
20 Low level spikes RSD 7.8%,  R2=0.998 RSD 11.9%, R2= 
0.996 
Spiked matrix NOT CORRECTED 
for recoveries 
21     NOT CORRECTED 
for recoveries 
22 S/N ratio at least 5 for LOQ coefficient correlation 
0.99999 
coefficient correlation 
0.99999 
use of reference 
materials 
CORRECTED for 
recoveries 
23 S/N, linearity with matrix RSD 11%, r2 0.995 RSD 2.3%, r2 0.998 spiked matrix CORRECTED for 
recoveries 
24 S/N ratio (3 and 10) of 
spiked samples 
r=0.9956 r=0.9888 spiked samples NOT CORRECTED 
for recoveries 
25 S/N 3 and 10 RSD 1%, correlation 
coefficient 0.9999 
3 %, correlation 
coefficient 0.9997 
spiked matrix CORRECTED for 
recoveries 
26 S/N ratio RSD: 4.60% and R: 
0.9994 
RSD: 3.64% and R: 
0.9994 
spiked matrix  on 
our own blank 
babyfood cereals 
matrix 
CORRECTED for 
recoveries 
27    Spiked matrix CORRECTED for 
recoveries 
28 S/N, blank and low level 
spike 
R2 0.999 R2 0.999 spiked matrix NOT CORRECTED 
for recoveries 
29 LOQ: S/N:10, low levels 
spikes 
RSD%: 14% ;  
R2>0.98 
RSD%: 7%; R2>0.98 spiked matrix NOT CORRECTED 
for recoveries 
30 Low level spike correlation coefficient 
0.999 
correlation coefficient 
0.999 
spiked matrix CORRECTED for 
recoveries 
31 Estimation; we didn't have 
the time to determine 
them exactly 
correlation coefficient 
0.9996 
correlation coefficient 
0.9989 
spiking of sample E NOT CORRECTED 
for recoveries 
32 LOQ: acc. to SANTE 
11945/2015 (Recovery 
between 70-120%, 
Standard deviation < 20%)  
RSD: 10.9%, R2: 0.97 RSD: 8.1%, R2: 0.96 two levels of spiked 
matrix at 1.0 and  
10 µg/kg 
NOT CORRECTED 
for recoveries 
  
41
/ LOD: lowest calibration 
level 
33 S/N ratio (3 and 10) of 
spiked blanks 
r=0.997896 r=0.999228 spiked blank 
matrices 
NOT CORRECTED 
for recoveries 
34 S/N ratio RSD 15%; correlation 
coefficient 0.9988 
RSD 3%; correlation 
coefficient 0.9990 
spiked matrix NOT CORRECTED 
for recoveries 
35 DIN 32645 (Calibration 
Curve with std.'s in low 
concentration) 
RSD 3.42%; r = 
0.9998 
RSD 6.27%; r= 
0.9998 
spiked Matrix NOT CORRECTED 
for recoveries 
36 LOD taken as lowest std 
0.03ug/l & LOQ lowest std 
multiplied by calculation 
factor in method supplied  
R2: 0.995428 R2: 0.997551 No spikes/recovery 
data 
NOT CORRECTED 
for recoveries 
37 Low level spikes   we used spiked 
matrix 
 
38 LOD S/N at least 3 LOQ 
S/N at least 10 
corr.coeff. 0.9988 corr.coeff. 0.9996 spike of an 
uncontaminated rye 
flour. calculation 
with a matrix 
calibration (with 
ISTD) 
NOT CORRECTED 
for recoveries 
39 Estimated from calibration, 
S/N ratio (3 and 9) 
CV (%) = 4.43 
r=0.99934 
CV (%) = 3.34 
r=0.99975 
spiked samples  
40 S/N ratio 3/6, respectively. RSD 8.0%; correlation 
coefficient 0.998 
17.0 %; correlation 
coefficient 0.999 
spiked matrix CORRECTED for 
recoveries 
41 Blanks used / low spike / 
S/N ratio 
RSD 21 %, correlation 
coefficient 0.999 
RSD 15%, correlation 
coefficient 0.999 
spiked matrix NOT CORRECTED 
for recoveries 
42 Low level spikes correlation coefficient: 
0.998 
correlation coefficient: 
0.999 
spiked matrix NOT CORRECTED 
for recoveries 
44 S/N ratio n.s. n.s. n.s. CORRECTED for 
recoveries 
45 S/N ratio (LOQ: 10; LOD: 
3), low level spikes 
RSD 9.5%; correlation 
coefficient 1.0000 
RSD 7%; correlation 
coefficient 0.9997 
spiked matrix NOT CORRECTED 
for recoveries 
46 LOD: S/N= 3 for C-
transition; LOQ: S/N= 6 for 
C transition, rounded to 
the next higher spiking 
level (e.g. 0.25, 0.5, 1 
ug/kg, etc) 
linearity: 0.999 linearity: 0.999 Sample spiked 
before extraction 
and sample extract 
spiked after 
extraction 
CORRECTED for 
recoveries 
47 S/N ratio 3 and 10 for LOD, 
LOQ resp. in low level 
spiked samples 
r=0.9993   
RSD=4.04% 
r=0.9988   
RSD=9.79% 
Matrix Spiked with 
internal Standard 
CORRECTED for 
recoveries 
49 We used low level spikes RSD%=7.48, r2= 
0.9971 
RSD%=2.72 , r2= 
0.9986 
spiked  matrix 
(wheat-flour) 
NOT CORRECTED 
for recoveries 
50 LOD S/N 10; LOQ: S/N 20 r= 0.999 r= 0.999  NOT CORRECTED 
for recoveries 
51 Parameters from the 
calibration curve 
RSD=2.91%, R2= 
0.9997 
RSD=4.94%, R2= 
0.9999) 
spiked matrix CORRECTED for 
recoveries 
52 LOD: S/N 3; LOQ: S/N 6 RSD%<7; R2=0.9949 RSD%<13; 
R2=0.9963 
spiked matrix NOT CORRECTED 
for recoveries 
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